BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  Boston Scientific Announces Acquisition of Obsidio, Inc.

  Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEM ™ ) technology used for embolization of blood vessels in the peripheral vasculature.

  August 15, 2022

   · 

  4 min read
• Business

  MediPharm Labs Reports Second Quarter Results

  MediPharm Labs Corp. today announced its financial results for the three and six months ended June 30, 2022.

  August 15, 2022

   · 

  10 min read
• Business

  Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Results and Provides Business Update

  Acurx Pharmaceuticals, Inc. announced today certain financial and operational results for the quarter ended June 30 , 2022.

  August 15, 2022

   · 

  9 min read
• Business

  BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update

  BrainStorm Cell Therapeutics today announced financial results for the second quarter ended June 30, 2022, and provided a corporate update.

  August 15, 2022

   · 

  14 min read
• Virios Therapeutics’ Announces Dosing of First Patient in IMC-2 Long-COVID Treatment Trial

  Virios Therapeutics, Inc. today announced commencement of enrollment in its exploratory Long-COVID trial.

  August 15, 2022

   · 

  5 min read
• Business

  BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care

  BeiGene today announced a strategic agreement with Ontada® to improve U.S. community oncology care through the development of real-world evidence (RWE) data, tools, and insights to help increase access to affordable, cutting-edge therapies.

  August 15, 2022

   · 

  7 min read
• Business

  Antibe Therapeutics Reports Q1 2023 Interim Financial and Operating Results

  Antibe Therapeutics Inc has filed its financial and operating results for the fiscal quarter ended June 30, 2022.

  August 15, 2022

   · 

  5 min read
• Business

  Gamida Cell Reports Second Quarter 2022 Financial Results and Provides Company Update

  Gamida Cell today provided a business update and reported financial results for the quarter ended June 30, 2022.

  August 15, 2022

   · 

  17 min read
• Business

  Ainos Reports Second Quarter 2022 Financial Results

  Ainos, Inc. today announced its unaudited financial results for the second quarter ended June 30, 2022.

  August 15, 2022

   · 

  10 min read
• Business

  atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update

  atai Life Sciences N.V. today reported financial results for the quarter ended June 30, 2022, and provided a business update.

  August 15, 2022

   · 

  16 min read